The QualityStocks Daily Wednesday, March 6th, 2019

Today's Top 3 StockMarketWatch

PoliticsAndMyPortfolio (BPTH) +160.46%

StocksToBuyNow (ZNGY) +100.00%

QualityStocks (NMEX) +63.46%

The QualityStocks Daily Stock List

BioCorRx, Inc. (BICX)

OTPicks, Damn Good Penny Picks, Penny Stock Newsletter, Equity Observer, SmallCapVoice, Value Penny Stocks, MassiveStockProfits, BUYINS.NET, PREPUMP STOCKS, Penny Picks, and PennyStocks24 reported previously on BioCorRx, Inc. (BICX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

BioCorRx, Inc. is a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions. The Company provides an innovative approach to the treatment of substance abuse addiction and has its BioCorRx® Recovery Program. The BioCorRx® Recovery Program is a non-addictive, medication-assisted treatment (MAT) program. BioCorRx’s emphasis is on improving the quality of life for recovering addicts. Listed on the OTCQB, the Company has its headquarters in Anaheim, California.

The BioCorRx® Recovery Program consists of two main components. The first component consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine, naltrexone, an opioid antagonist that can considerably reduce physical cravings for alcohol and opioids. The second component is a one-on-one proprietary counseling program. It is mainly tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatments.

BioCorRx has also expanded the support structure to include 12 months of a peer-support system using trained recovery specialists. In addition, the Company is developing a patent pending injectable form of naltrexone.

BioCorRx Pharmaceuticals is the Company’s research and development (R&D) subsidiary. At present, BioCorRx Pharmaceuticals is developing a new injectable naltrexone technology (BICX101) through a partnership with TheraKine Ltd. BICX101 is a sustained release, injectable naltrexone for the treatment of opioid abuse and alcoholism. BioCorRx’s plan is to seek Food and Drug Administration (FDA) approval for BICX101 and/or its naltrexone implant product(s).

This past May, BioCorRx® announced that it submitted a grant application to the National Institutes of Health (NIH) to fund the development and study plans for BICX102, its sustained release naltrexone implant for the treatment of opioid and alcohol use disorders. Moreover, in June, the Company announced it completed a capital raise of $1.1 million. This capital enables BioCorRx to continue to work towards FDA approval of BICX102.

BioCorRx, Inc. (BICX), closed Wednesday's trading session at $4.05, up 1.25%, on 1,452 volume with 8 trades. The average volume for the last 3 months is 115,314 and the stock's 52-week low/high is $3.50/$10.00.

chart

Lightwave Logic, Inc. (LWLG)

StockGuru, OTC Picks, Standout Stocks, FeedBlitz, PennyStocks24, SmallCap Fortunes, SmallCapVoice and HotOTC reported previously on Lightwave Logic, Inc. (LWLG), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Lightwave Logic is a technology business concentrating on the development of Next Generation Photonic Devices and Non Linear Optical Polymer Materials Systems for applications in high-speed fiber-optic data communications and telecommunications. The Company creates prototype electro-optic demonstration devices. Lightwave Logic is based in Longmont, Colorado. The Company lists on the OTC Markets Group’s OTCQB.

Lightwave Logic is moving toward commercialization of next generation photonic devices utilizing its high-activity and high-stability organic polymers for applications in data communications and telecommunications markets. The Company is using organic nonlinear electro-optical and all-optical polymers (plastic) as the foundation for a series of proprietary (internal and licensed to external partners) advanced Integrated Optical Devices that have wide-ranging applications in telecommunications, data communications, and optical computing for use in commercial and military markets.  

Lightwave Logic has integrated its proprietary Perkinamine™ chromophore technology with other chromophores based in part on components of proprietary, in-licensed technologies. This has resulted in a strong and durable nonlinear organic electro-optical (EO) material, which will be used in photonic device development. It is founded on the Company’s multi-chromophore approach that enables two or more chromophores to work in concert.

The Polymer Photonics Integrated Circuit (P2ICTM) is similar to an electronic integrated circuit. However, it incorporates two or more optical functions or devices integrated onto a single substrate platform. Lightwave Logic’s expectation is that P2ICsTM will become a vital engine in the transceiver market over the next decade. The Company is developing its P2IC into prototypes.

Lightwave Logic announced earlier this year that it successfully demonstrated, together with its packaging partner, packaged polymer modulators designed for 50Gbps. The Lightwave Logic technical team worked together with its partner to complete the design with detailed attention paid to optical and electrical signaling issues.

In July, Lightwave Logic announced that Dr. Karen Liu joined the Company as Vice President of Sales and Marketing. Dr. Liu is a well-known industry analyst and marketing executive in Datacom and Telecom fiber optic communications. Her role at Lightwave Logic will be to advance the Company’s customer-facing position in the datacom and telecom markets via her technical, business, and investor expertise. Dr. Liu will help Lightwave Logic release 400Gbps and 800Gbps products based on the Company’s polymer PIC platform. 

Lightwave Logic, Inc. (LWLG), closed Wednesday's trading session at $0.89625, up 10.65%, on 410,216 volume with 224 trades. The average volume for the last 3 months is 113,701 and the stock's 52-week low/high is $0.62/$1.33.

chart

Nutra Pharma Corp. (NPHC)

Serious Traders, PennyStocks24, Streetwise Reports, MyBestStockAlerts, BUYINS.NET, UndiscoveredEquities, Wallstreetlivechat, Innovative Marketing, StocksToBuyNow, Pumps and Dumps and Winston Small Cap reported previously on Nutra Pharma Corp. (NPHC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nutra Pharma Corp. is a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. These include Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. The Company is marketing Nyloxin® and Pet Pain-Away™ in the Over-the-Counter (OTC) pain management market. Listed on the OTC Markets, Nutra Pharma is headquartered in Coral Springs, Florida.

Via its subsidiaries, Nutra Pharma carries out basic drug discovery research and clinical development. The emphasis of the Company’s approach to drug discovery and the development of new therapeutic agents are based on specialized receptor-binding proteins found in nature, especially those found in snake venom from the cobra.

Nutra Pharma’s leading drug candidates are RPI-78M and RPI-MN. Its MS drug RPI-78M was previously granted Orphan Status by the Food and Drug Administration (FDA) for the treatment of Pediatric Multiple Sclerosis. The Company’s RPI-MN inhibits the entry of numerous viruses known to cause severe neurological damage in diseases such as encephalitis and AIDS. RPI-MN is undergoing development initially for the treatment of HIV. RPI-78M is undergoing development for the treatment of multiple sclerosis (MS).

The Company also looks for strategic licensing partnerships to lessen the risks associated with the drug development process. Its holding, ReceptoPharm, is developing technologies to produce drugs for HIV and MS. Nutra Pharma’s subsidiary, Designer Diagnostics, engages in the research and development (R&D) of diagnostic test kits designed to be used for the fast identification of infectious diseases. These include Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).

Nutra Pharma offers a number of drug products for sale for pain treatment. One is Nyloxin®, the first OTC pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Nutra Pharma has launched Luxury Feet. This is a new version and packaging of its OTC pain drug Nyloxin. Another product is Nyloxin Extra Strength, the only non-narcotic and non-addictive treatment for severe (Stage 3) pain.

Nutra Pharma also has its Pet Pain-Away. This is the first OTC product to treat pain in companion animals without side effects. Pet Pain-Away is a homeopathic, non-narcotic, non-addictive, OTC pain reliever.

Last month, Nutra Pharma announced that it executed an agreement with American Marketing Technologies (AMT) to launch an integrated Internet marketing campaign united with a program to target several national retail chains. Recently, the Company re-launched its product websites. In addition, Nutra Pharma recently announced the infomercial campaigns specifically promoting Pet Pain-Away™.

Nutra Pharma Corp. (NPHC), closed Wednesday's trading session at $0.0004, up 33.33%, on 3,194,087 volume with 6 trades. The average volume for the last 3 months is 5,010,646 and the stock's 52-week low/high is $0.00009/$0.0035.

chart

Isodiol International, Inc. (ISOLF)

Investopedia, Stockhouse, OTC Markets, Wealth Daily, and InvestorsHub reported on Isodiol International, Inc. (ISOLF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Isodiol International, Inc. specializes in the development of pharmaceutical and wellness products. Its growth strategy includes the development of over-the-counter (OTC) and pharmaceutical drugs and expanding its phytoceutical portfolio. A global CBD innovator, Isodiol International is based in Vancouver, British Columbia. Be Trū Wellness (Be Tru) is a wholly-owned subsidiary of the Company.

Isodiol is continuing international expansion into Latin America, Asia, and Europe. The Company specializes in hemp-based health and wellness products and the development of pharmaceutical CBD delivery methods. In addition, Isodiol specializes in the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical products (FPPs).

Isodiol International is the market leader in pharmaceutical grade phytochemical compounds. Furthermore, the Company is the industry leader in the manufacturing and development of phytoceutical consumer products.

Isodiol produces raw ingredients, consumer packaged goods, including dietary supplements, food and beverages, skin care, and pharmaceutical products for the worldwide healthcare market. Regarding consumer products, it develops its own family of product brands for retail sale.

Regarding raw ingredients, Isodiol develops natural phytoceutical derivatives and delivery technologies. Additionally, Isodiol develops white label products and brands for wholesale customers. Concerning pharmaceuticals, the Company supplies raw phytoceutical ingredients.

The Company has acquired worldwide licensing rights for IsoDerm™ and five other proprietary pharmaceutical compounds to be delivered by the patented Direct Effects Technology™. This is a back of the neck delivery system from its developer Dr. Ronald Aung-Din, MD.

Isodiol International has its ImmunAG™. This product is the market’s first non-cannabis cannabidiol (CBD) product derived from the hops plant. This is a time-released tablet. The ImmunAG tablet does not dissolve in the stomach. It dissolves in the lower intestine, thus creating greater bioactivity.

This week, Isodiol International announced the progress of its months-long efforts to develop new hemp-based beers and functional beverages. In May of this year, IsoBev, Inc., a wholly-owned subsidiary of Isodiol International, acquired a turn-key brewing system.

The brewing system includes a 7-bbl brewhouse, four 15-bbl fermentation tanks, a 30-bbl fermentation tank, a 15-bbl brite tank, and a 30-bbl brite tank, expected to yield between 1,500 and 2,000 bbls of production annually.  In addition, IsoBev also acquired a 12-ounce bottling line and a 22-ounce bottling line that could yield greater than 600,000 12-oz bottles and 25,000 12-oz bottle cases annually.

Mr. Marcos Agramont, Isodiol International’s Chief Executive Officer, said, We believe there is a significant demographic within the existing beer, wine, and spirits and health and wellness consumer markets that is open to unique beverage experiences, with a particular interest in cannabinoid-rich carbonated beverages.”

Isodiol International, Inc. (ISOLF), closed Wednesday's trading session at $0.9697, down 0.03%, on 69,680 volume with 90 trades. The average volume for the last 3 months is 238,100 and the stock's 52-week low/high is $0.7833/$12.00.

chart

OWC Pharmaceutical Research Corp. (OWCP)

Insider Financial, The Street, OTC Markets, Promotion Stock Secrets, Street Register, The Profit Buzz, CFN Media Group, Stock Invest, TipRanks and Cannabis Financial Network News reported on OWC Pharmaceutical Research Corp. (OWCP), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

OWC Pharmaceutical Research Corp. engages in the research and development (R&D) of cannabis-based medical products. The Company provides medical products for the treatment of different medical conditions and/or diseases. These include multiple myeloma, psoriasis, PTSD, migraines, as well as delivery systems. OWC Pharmaceutical Research has its corporate headquarters in Petach Tikva, Israel. The Company lists on the OTCQB.

OWC Pharmaceutical Research has entered into research and collaboration agreements with three of the leading research institutions in Israel. These include Sheba Academic Medical Center, one of the foremost academic hospitals in the Middle East. These agreements serve as the foundation for the Company’s clinical trials. They ensure that all of its studies have been, and will continue to be, based on established research protocols of the U.S. Food and Drug Administration (FDA), Institutional Review Boards, and Independent Ethical Committees.

One World Cannabis Ltd. is a wholly-owned subsidiary of OWC Pharmaceutical Research. One World Cannabis’ Research Division centers on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of varied medical conditions. Its Consulting Division’s dedication is to helping governments and companies navigate complex international cannabis regulatory frameworks.  

OWC Pharmaceutical Research has completed the development of a proprietary, cannabinoid-enriched sublingual tablet for the administration of medical cannabis. The technology behind the tablet is protected. It provides for the ingestion of almost any dosage of medical cannabis with a sublingual delivery mechanism, where the compounds are absorbed directly into the patient's blood through oral epithelial tissue.

OWC has received the first ever Institutional Review Board (IRB) approval to conduct a safety study for a cannabis-based topical cream with more than 3 percent THC.  OWC is conducting a safety study (FDA Phase 1 equivalent) in one of the largest academic hospitals in Israel.

At the beginning of August, OWC Pharmaceutical Research announced the start of the final stage of its Phase I, placebo controlled, maximal dose study (Psoriasis Study) to determine the safety and tolerability of topical ointment containing medical grade cannabis in healthy volunteers. On June 28, 2018, OWC announced that it successfully completed the first stage of this trial that consisted of the single dosing of healthy volunteers.

The final stage of the trial consists of the twice daily dosing of healthy volunteers for six weeks. The study is being performed by Professor Aviv Barzilai, Director of the Department of Dermatology at Chaim Sheba Medical Center.

OWC Pharmaceutical Research Corp. (OWCP), closed Wednesday's trading session at $0.0395, up 3.95%, on 1,582,470 volume with 101 trades. The average volume for the last 3 months is 1,149,114 and the stock's 52-week low/high is $0.0372/$0.34.

chart

Timberline Resources Corp. (TLRS)

Amigo Bulls, Zacks, MarketWatch, InvestorsHub, Real Investment Advice, Market Screener, Marketbeat, and Gold Investment Letter reported on Timberline Resources Corp. (TLRS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Timberline Resources Corp. is a gold exploration and development company. Its operational focus is the State of Nevada. The Company’s flagship Talapoosa Project is a partially permitted, open-pit, heap leach gold project with low capital and operating costs and strong economics. Furthermore, its exploration efforts have been centered on its 23 square-mile Eureka land package. This is one of the largest remaining undeveloped gold properties in Nevada. OTCQB-listed, Timberline Resources has its corporate office in Coeur d’Alene, Idaho.

Timberline is refocusing its exploration efforts on advancing the Windfall and Lookout Mountain projects at its Eureka property. This is concurrent with relinquishing its option to acquire the Talapoosa project.

Concerning the Eureka land package, it includes Timberline’s Lookout Mountain project and a pipeline of earlier-stage projects, which feature past gold production, historic gold estimates, and/or drill-indicated gold mineralization. Eureka is on the south end of Nevada’s Battle Mountain/Eureka Trend.

The Company continues to advance its Lookout Mountain and Windfall project areas at Eureka. In 2012, it purchased a large block of patented and unpatented mining claims. These consist of chiefly the entire Seven Troughs gold mining district near Lovelock in Pershing County, Nevada.

The purchased property package encompasses 4,100 acres. It comprises 64 patented and 238 unpatented lode mining claims, all which are under a long-term lease agreement, along with 162 additional unpatented lode mining claims.

Earlier this month, Timberline Resources announced that recently completed rock chip sampling confirms high-grade gold mineralization within the historic Windfall Mine area of the 23 square-mile Eureka property in Nevada. The Windfall Mine open pit is centrally located on the Windfall trend. This zone extends 1.7 miles (2.7 km) from north to south. The Company plans to conduct more drilling in support of an initial open-pit oxide resource study.

Last week, Timberline Resources announced that it closed on the acquisition of ownership interests in two Nevada gold-copper mineral properties in the Battle Mountain mining district in Nevada from Americas Gold Exploration, Inc. (AGEI). The acquisition includes the right to earn into existing Joint Venture agreements with McEwen Mining, Inc. at the Elder Creek Project (Elder Creek Joint Venture), and with Lac Minerals (USA) LLC, a wholly-owned subsidiary of Barrick Gold Corporation (LAC) at the Paiute Project (Paiute Joint Venture).

Timberline Resources Corp. (TLRS), closed Wednesday's trading session at $0.07, even for the day, on 27,034 volume with 4 trades. The average volume for the last 3 months is 26,530 and the stock's 52-week low/high is $0.00009/$0.2136.

chart

Beleave, Inc. (BLEVF)

NetworkNewsWire, The Street, InvestorsHub, Business Insider, InvestingNews, Cannabis Newswire, ResearchPool, 4-Traders, MidasLetter, Daily Marijuana Observer, Weed Newswire, Penny Stock Tweets, OTC Markets, New Cannabis Ventures, Equities, MarketWatch, Morningstar, Wallet Investor, InvestorsHangout, Stockhouse, Barchart, PrimedEquities, Marketwired, and TradingView reported on Beleave, Inc. (BLEVF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Beleave, Inc. is a diversified biotechnology company with a purpose-built ACMPR licensed cannabis facility near Hamilton, Ontario. Moreover, it has patient services clinics operating throughout Ontario under the Medi-Green brand. The Company's wholly-owned subsidiary is Beleave Kannabis Corp. Beleave lists on the OTC Markets Group’s OTCQX.

The Company has decades of growing experience coupled with industry leading equipment. Beleave’s aim is to provide a consistent, reliable and standardized product to suit the needs of every person.

Beleave concentrates on green initiatives. It grows its plants using no pesticides. In addition, the Company’s facilities host a large-scale, commercial, solar installation, which substantially offsets its carbon footprint. Beleave’s water supply is on a closed loop system to recycle every drop.

Beleave’s products include Shishkaberry, CBD god bud, and Cold Creek Kush. Shiskaberryʼs buds have a fruit and berry aroma with shades of purple. CBD god bud was created by mixing an almost pure Sativa strain named Hawaiin with a very strong purple Indica strain. Cold Creek Kush is an Indica-dominant hybrid. It crosses the strong MK Ultra and Chemdawg 91.

In May, Beleave announced that it added another location to its network of Medical Cannabis Clinics. The new location is located at 211 Dundas Street in London, Ontario. The Company recently closed on the acquisition of the Medi-Green Cannabis Clinic Network.  London, Ontario is Beleave’s fourth clinic joining three Ontario locations already open in Hamilton, Kingston, and Perth.

In July, Beleave announce the acquisition of 100 percent of the outstanding shares of Seven Oaks, Inc. in an all share deal valued at $3,000,000. This acquisition follows important news of Seven Oaks branded cannabis products being chosen by Manitoba Liquor and Lotteries Corporation and the BC Liquor Distribution Branch for sale to consumers in deals anticipated to generate initial revenues of more than $2,900,000. Beleave is preparing to launch Seven Oaks-branded cannabis flower, pre-rolls, as well as oils after October 17, 2018.

This week, Beleave announced it was selected by the Ontario Cannabis Store (OCS) for sale of its Seven Oaks brand. Beleave will package and sell three strains of its cannabis products under the Seven Oaks brand at launch. The Company will continue to expand options for consumers as new varieties become available.

Beleave, Inc. (BLEVF), closed Wednesday's trading session at $0.075, down 1.32%, on 338,355 volume with 40 trades. The average volume for the last 3 months is 375,918 and the stock's 52-week low/high is $0.05/$0.282857.

chart

Northern Minerals & Exploration Ltd. (NMEX)

Penny Stock Tweets, SmallCapVoice, Proactive Investors, OTC Markets, Wallet Investor, 4-Traders, Stockhouse, Mining Feeds, MarketWatch, TopPennyStockMovers, InvestorsHub, Marketwired, Junior Mining Network, Club Penny Stocks Network, OTPicks, OTCBB Journal, Orbit Stocks, Northern Miner, and First Penny Picks reported on Northern Minerals & Exploration Ltd. (NMEX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Northern Minerals & Exploration Ltd. is a natural resource company listed on the OTC Markets. Its emphasis is on oil and gas exploration & production in Texas, gold & silver exploration in Nevada, and hotel & resort development in Mexico. The Company previously went by the name Punchline Resources Ltd. It changed its corporate name to Northern Minerals & Exploration Ltd. in August of 2013. Northern Minerals & Exploration has its head office in Quitman, Texas.

In 2017, Northern Minerals & Exploration entered into a Letter of Intent (LOI) with a private Mexican entity to work together and conduct due diligence for participating in projects in Mexico with a first focus on a property in the State of Quintana Roo. The Property is a part of the Riviera Maya. It is situated near the recently discovered Ichkabal Mayan ruins. It is located on the Caribbean coast of the Yucatan Peninsula. The Company considers the Property to have significant potential for resort development.

In June, Northern Minerals & Exploration announced that significant events have occurred over the past six months for the Company. It moved from an LOI to a Memorandum of Understanding (MOU) on Joint Venture (JV) development of the Hotel & Resort Property on Yucatan Peninsula, Mexico.

Moreover, the Company established a Mexican Subsidiary - Enmex Operaciones to be able to commence Real Estate Development Projects in Mexico. It also hired an award winning Architectural Firm to design the masterplan for a 40 room Boutique Hotel & Resort, Spa & Wellness Center with 40 Luxury Villas and 50 High End Condos.

Furthermore, Northern Minerals & Exploration formed Kathis Energy LLC, as a wholly-owned subsidiary that is establishing oil and gas operations in west and south Texas. Kathis Energy created Two Private Placement Drilling funds. One is a $5,250,000 drilling fund for 8 wells in central west Texas. The other is a $30,000,000 drilling fund for 25 wells in south Texas. Kathis Energy’s forte is to go back into abandoned or plugged out oil fields, which were considerable producers and recover the significant oil reserves that were left behind.

The Company also completed a CSMAT Survey on the Winnemucca Mountain Gold Property. The Winnemucca Mountain Property comprises greater than 2600 acres+/- in Humboldt County, in northwestern Nevada. The Property is near the northern end of the highly productive Battle Mountain-Eureka mineral trend.

Recently, Northern Minerals & Exploration announced the expansion of the Board of Directors and Officers. On Friday, July 6, 2018, Mr. Howard Siegel, sole Director of the Company, added Noel Schaefer and Victor Miranda to the Board effective immediately. The new Board appointed a new group of Officers: Ivan Webb, Chief Executive Officer; Victor Miranda, Chief Financial Officer; Noel Schaefer, Chief Operations Officer; Roger Autrey, VP Business Development & Secretary; and Mark Seitz, VP Director of Operations.

Northern Minerals & Exploration Ltd. (NMEX), closed Wednesday's trading session at $0.08, up 95.12%, on 1,300 volume with 1 trade. The average volume for the last 3 months is 13,735 and the stock's 52-week low/high is $0.0155/$0.10.

chart

Lixte Biotechnology Holdings, Inc. (LIXT)

Stockhouse, 4-Traders, Real Pennies, MarketWatch, InvestorsHub, and Simply Wall St reported on Lixte Biotechnology Holdings, Inc. (LIXT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings, Inc. is a drug discovery company based in East Setauket, New York. The clinical-stage Company utilizes biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. Lixte’s product pipeline encompasses two major categories of compounds at different stages of pre-clinical and clinical development that the Company believes have wide-ranging therapeutic potential for cancer and other debilitating and life-threatening diseases. Lixte Biotechnology lists on the OTCQB.

The Company’s cancer drug development strategy has led to the discovery of novel compounds. These have the potential to be therapeutically useful against several other important but seemingly dissimilar diseases.

The phosphatase inhibitors are in pre-clinical development for lessening the extent of tissue damage following stroke, heart attack, and septic shock. The deacetylase inhibitors are in pre-clinical development for the prevention and treatment of neurodegenerative diseases, traumatic brain injury, and topically for fungal dermatitis.

Lixte’s commitment is to discovering drugs for more effective treatments for cancer. It has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models.

The Company’s current drug portfolio includes inhibitors of protein phosphatases, which are vital to cell division and DNA damage repair, and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.

Lixte Biotechnology’s unique phosphatase inhibitor is LB-100, its lead compound. LB-100 is in a Phase I clinical trial at two NCI designated Comprehensive Cancer Centers and three U.S. Oncology Research locations.

Lixte Biotechnology granted an exclusive license of its LB-100 for the treatment of hepatocellular carcinoma (HCC) in Asia to Taipei Medical University (TMU). LB-100 is not currently approved for treatment of HCC.

Under the license, Taipei Medical University will ascertain the effectiveness of LB-100 against HCC in clinical trials conducted in compliance with Taiwanese and U.S. regulatory requirements. TMU will pay milestone and royalty payments to Lixte Biotechnology.

In February, Lixte Biotechnology Holdings noted that investigators at the Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, reported on February 7, 2018 (Lai et al., Sci. Transl. Med.10, eaan8735 (2018)) that in animal models the Company’s protein phosphatase 2A (PP2A) inhibitors overcome resistance of chronic myelogenous leukemia (CML) cells to standard treatment.

Dr. John S. Kovach, Lixte Biotechnology Holdings’ Chief Executive Officer, said "The vast majority of CML cells are killed by drugs called tyrosine kinase inhibitors (TKI), the prototype of which is imatinib (Gleevec), considered the first truly targeted form of chemotherapy. … The Terry Fox investigators found inhibition of PP2A with LB-100 or LB-102 preferentially sensitizes these resistant CML cells to killing by TKI compared to normal bone marrow stem cells. If these results can be replicated in the clinic, LB-100 and analogs may further improve the effectiveness of CML therapy.”

Lixte Biotechnology Holdings, Inc. (LIXT), closed Wednesday's trading session at $0.86, up 4.88%, on 1,027 volume with 2 trades. The average volume for the last 3 months is 3,745 and the stock's 52-week low/high is $0.125/$1.84.

chart

Bravo Multinational, Inc. (BRVO)

RedChip, InvestorsHub, and MarketWatch reported on Bravo Multinational, Inc. (BRVO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Bravo Multinational, Inc. is a diversified Company listed on the OTC Markets Group’s OTCQB. Its primary focus is the development and expansion of the Casino Gaming Equipment holdings and business-related activities in Central and South America (specifically Nicaragua, El Salvador, and San Andres, Columbia). The Company’s multi-divisional growth strategy is driven via mergers, acquisitions, as well as new ventures.

The Company previously went by the name Goldland Holdings Co. It changed its corporate name to Bravo Multinational, Inc. in April 2016. Bravo Multinational has its head office in Niagara-on-the-Lake, Ontario.

At present, Bravo Multinational has divisions in Mining Properties and Casino Equipment. The Company, as it develops, will be adding divisions in International Business Consulting, Wholesale and Manufacturing, and Real Estate Acquisitions. In addition, Bravo holds gold/silver mining properties and claims in North America.

Pertaining to Mining Assets, this involves War Eagle Mines, Silver City, Idaho. Bravo executed a lease agreement with Silver Falcon Mining. This agreement provides for a yearly lease payment of $1,000,000 payable in monthly installments of $83,333 per month, and a royalty equal to 15 percent of the proceeds of any ore mined from Bravo Multinational property on War Eagle Mountain.

The Company’s Mining Assets (Current Claims) include the Poorman Lode Claim – Ownership Interest (OI) 29.167 percent; the London Lode Claim – OI 29.167 percent; the North Empire Lodge Claim - OI 29.167 percent; and the Illinois Central Lode Claim - OI 29.167 percent.

Current Claims also include the South Poorman Lode Claim – OI 29.167 percent; the Jackson Lode Claim - 29.167 percent; and the Oso Lode Claim - 29.167 percent.

Concerning Casino Gaming, Bravo completed an acquisition transaction on May 6, 2016 with Centro de Entretenimiento y Diversion Mombacho S.A., based in Managua, Nicaragua. Bravo received its first income from this business venture on June 1, 2016. Additional income payments will be received on the first of each month.

Regarding this transaction, the Company is purchasing, in total, 500 slot and video poker gaming machines. All machines have been fully nationalized and are to be operated under a long-term (year 2033) nationwide national license.

On August 16, 2017, Bravo completed an asset purchase for 300 slot and video poker machines. This provided an immediate new revenue stream for the Company.

The value of the contract is $3,618,000. The Company expects a roughly 30 percent annual return on the assets in Latin America, based on historical income data in comparable locations.

Bravo Multinational announced in August of 2017 its current review of a potential new “Casino Gaming” operation venture. Moreover, the Company announced its review of diversified business opportunities in the legalized marijuana (MJ) sector in Canada.

The Company commenced a comprehensive review of a large pending commercial “Marijuana Grow” operation with related real estate holdings for a possible joint venture (JV) investment, in Central Ontario, Canada. The licensing process for this venture is currently pending Health Canada’s government approvals.

Bravo Multinational, Inc. (BRVO), closed Wednesday's trading session at $0.50, up 7.54%, on 43,992 volume with 9 trades. The average volume for the last 3 months is 8,518 and the stock's 52-week low/high is $0.209/$0.95.

chart

Butler National Corp. (BUKS)

Zacks, Marketbeat.com, MarketWatch, and Feed Blitz reported previously on Butler National Corp. (BUKS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Butler National Corp. is a top manufacturer and provider of support systems for commercial and military aircraft. The Company is also a recognized provider of management services in different business groups. These include the gaming industry. Butler is a leader in the growing global market for aircraft structural modification, maintenance, repair and overhaul (MRO). Listed on the OTCQB, Butler National is based in Olathe, Kansas.

The Company formed in 1968 through the merger of an aviation research firm owned by the Butler family and National Connector Corporation. Butler National combined resources of the two companies to develop one of the first commercial Area Navigation Systems (RNAV) used for airplane navigation.

Butler’s subsidiaries include Avcon Industries, Inc.; Butler Avionics, Inc.; BCS Design, Inc.; Boot Hill Casino & Resort; The Stables Casino; and Butler National-Tempe. Avcon Industries provides aircraft owners and operators with products and services designed to satisfy special mission requirements, or enhance the utility of business jets and turboprops.

Butler National’s Aerospace segment concentrates on the manufacturing of support systems for "Classic" commercial and military aircraft. This includes the Butler National TSD for the Boeing 737 and 747 Classic aircraft. In addition, this segment concentrates on switching equipment for Boeing McDonnell Douglas Aircraft, weapon control systems for Boeing Helicopter, and performance enhancement structural modifications for Learjet, Cessna, Dassault, and Beechcraft business aircraft.

Boot Hill Casino & Resort is in Dodge City, Kansas. It is home to the first state owned and operated casino gaming in Kansas. The Stables Casino is a Class III gaming establishment in Miami, Oklahoma. The Miami Tribe and the Modoc Tribe owns it.

Butler National-Tempe operates in the Defense Contracting & Electronics industry. Butler’s Management Services segment includes temporary employee services, gaming services, and administrative management services. Butler Avionics’ services include new installations and retrofits, to avionics, autopilot, instruments, as well as radar troubleshooting and repair. Furthermore, BCS Design is a full-service architectural firm.

Last month, Butler Avionics, the subsidiary of Butler National, announced European Aviation Safety Agency (EASA) Supplemental Type Certificate (STC) approval of the Butler National ADS-B (Out) avionics solution in the Learjet Model 35, 35A, 36, 36A and Lear 60.

The EASA approved STC modification, STC Number 10063974, provides an independent ADS-B(Out) system with the installation of the Garmin GTX 3000 Transponders, the GDL 88 (Dual Band UAT/1090 Receiver with WAAS GPS Sensor) and the Flight Stream 210 Bluetooth Transmitter in the Learjet 35, 35A, 36, 36A and Learjet Model 60 airplanes. This system provides a seamless interface to most TCAS II equipment. It does so while providing the crew optional access to ADS-B(In) when within the U.S. In addition, in December, Butler National announced its financial results for Q2 fiscal 2018 ended October 31, 2017. Q2 fiscal 2018 resulted in a Net Income of $84,000 versus a Net Income of $519,000 in Q2 fiscal 2017.

The Company stated: “Revenue decreased 13 percent to $11.2 million in the three months ended October 31, 2017, as compared to $12.8 million in the three months ended October 31, 2016. The decrease in revenue reflects a decrease in Aerospace Products revenue (down 25 percent) and a decrease of 5 percent in Professional Services revenue. Butler National Corporation continues to drive growth in international markets and through the development of new supplemental type certificates. This includes significant efforts in South America, Europe, Africa, and Asia.”

Butler National Corp. (BUKS), closed Wednesday's trading session at $0.37, up 5.71%, on 450 volume with 1 trade. The average volume for the last 3 months is 35,965 and the stock's 52-week low/high is $0.18/$0.40.

chart

Kiwa Bio-Tech Products Group Corporation (KWBT)

The Stock Psycho, Top Gun, Penny Stock Rumble, StockMister, The Penny Play, Equities.com, SmallCapVoice, Wallstreetlivechat, Lions of Wall Street, Fast Moving Stocks, Darth Trader, and OTC Picks reported earlier on Kiwa Bio-Tech Products Group Corporation (KWBT), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Kiwa Bio-Tech Products Group Corporation is a manufacturer concentrating on eco-friendly bio-based fertilizers promoting soil health. The Company develops, manufactures, distributes, and markets novel, cost-effective and environmentally safe bio-technological products for agricultural and environmental conservation. Kiwa Bio-Tech Products Group is based in Claremont, California.

The Company’s commitment is to eco-agricultural development and environmental control through developing, producing, and selling bio-technological products with high technology, low-cost, and high productivity to satisfy growing market demand. Kiwa Bio-Tech’s dedication is to making safe food, further developing eco-agriculture, and upholding a responsibility of contributing to China's agricultural safety, food safety, and a healthy lifestyle.

The design of the Company’s products is to enhance the quality of human life through increasing the value, quality, and productivity of crops and reducing the negative environmental impact of chemicals and other wastes. Kiwa Bio-Tech utilizes new bio-technological skills at its core. Organic, ecologically sound, and "green" practices are its theme.

Kiwa Bio-Tech has a strategic cooperation agreement with the Beijing Zhongpin Agricultural Science and Technology Development Center (Zhongpin Center). Zhongpin Center is the Chinese Agricultural Science and Technology Innovation and Development Committee's executive implementation agency (called the Agricultural Science and Technology Commission).

Through the guidance and support by the Zhongpin Center, Kiwa Bio-Tech will participate and be involved in China's National Soil Remediation Program and construction of the National Ecological Security Agriculture Industrial Chain Standardization System's operation and process.

Kiwa Bio-Tech has launched a joint venture (JV) with Zhongshi'an Agricultural Science & Technology Co., Ltd. and Xintaitianyi Financial Service and Science & Technology Co., Ltd. The name of the JV is Inner Mongolia Jingnong Investment Management Co. Ltd.

Kiwa Bio-Tech is a 40 percent partner in the venture. This venture will have an initial capitalization of roughly $1.5 million. Jingnong will invest in the expansion of Kiwa Bio-Tech’s existing production base in Shandong Province and in the construction of three new manufacturing bases of Kiwa in Inner Mongolia Province, Xinjiang Province, and Guizhou Province.

Recently, Kiwa Bio-Tech announced that it completed a repositioning and updating of its products. This is to meet the diverse market demands for biological organic fertilizers. The Company’s intention is that all of the new updated products will enter into the market next year.

The Company’s new products structure includes 16 types of products in 5 major categories. These categories are Biological Organic Fertilizer, Compound Microorganism Fertilizer, Microorganism Bacterium Agent, Biological Soluble Fertilizer, and Organic-Inorganic Compound Fertilizer.

Kiwa Bio-Tech Products Group Corporation (KWBT), closed Wednesday's trading session at $0.72, down 26.53%, on 3,482 volume with 5 trades. The average volume for the last 3 months is 2,681 and the stock's 52-week low/high is $0.27/$1.60.

chart

REGI U.S., Inc. (RGUS)

MarketWatch, Marketwired, and Stockhouse reported on REGI U.S., Inc. (RGUS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

REGI U.S., Inc. via its subsidiary, RadMax Technologies, Inc., engages in the design and development of axial vane-type rotary engines, known as the RadMax rotary technology, used in the design of engines, compressors, and pumps. RadMax Technologies is developing for commercialization multiple improved axial vane type rotary devices utilizing its Patented RadMax™ Rotary Technology. OTCQB-listed, REGI U.S. is based in Spokane, Washington.

The RadMax™ Rotary Technology allows for ground-breaking designs of lightweight and high efficiency engines, compressors, pumps, as well as other devices. One current prototype is The RadMax™ engine. It has only two unique moving parts, the vanes (up to 12) and the rotor, versus the 40 moving parts in a basic four-cylinder piston engine.

The inventive design makes it possible to produce up to 24 continuous power impulses per one rotation, which is vibration-free and very quiet. In addition, the RadMax™ engine has a number of capabilities permitting it to operate on fuels such as gasoline, natural gas, hydrogen, propane, and diesel.

Recently, the Board of Directors of REGI U.S. and its wholly owned subsidiary, RadMax Technologies announced engineering improvements and prototype testing results. Because of the Company’s research, testing, and prototype development, the Board also announced the filing of two new patents and three provisional patents. Furthermore, other designs and RadMax technology enhancements are in the plans for future patent consideration.

This month, the Board of Directors of Regi U.S. and RadMax Technologies announced the appointment of Mr. Paul L. Porter as President of Regi U.S. and RadMax Technologies. The Board of Directors selected Mr. Porter to fill the role of President and Chief Technology Officer (CTO) after having served as its VP Engineering for the last year.

Mr. Porter has a wide-ranging background in Mechanical Engineering. He has built a globally respected aerospace seal technology company. Also, he has continually advanced the RadMax Technology. As President, he will serve as the principal technology voice of the Company. Additionally, he will work alongside Mr. Paul W. Chute, the Chief Executive Officer (CEO), in advancing Regi U.S. and RadMax Technologies.

In essence, the Company’s objective is to license RadMax technology and/or participate in joint ventures (JVs) to manufacture RadMax products for specific applications. Market segments that could benefit from RadMax technology include (but are not limited to) transportation, aerospace, air conditioning and refrigeration, oil and gas production and distribution, power generation, marine, and military markets.

REGI U.S., Inc. (RGUS), closed Wednesday's trading session at $0.074, up 13.85%, on 11,225 volume with 3 trades. The average volume for the last 3 months is 22,953 and the stock's 52-week low/high is $0.0052/$0.125.

chart

Gopher Protocol, Inc. (GOPH)

OTCtipReporter, PennyStockScholar, Wall Street Mover, Profitable Trader Authority, PennyTrader, and Integrity Solution IR reported earlier on Gopher Protocol, Inc. (GOPH), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Gopher Protocol, Inc. is developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology. A development stage enterprise, Gopher Protocol provides a mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional features. The Company’s Integrated Circuit (IC), which goes by the name GopherInsight™, and accompanied software, creates a private and secured network for sharing information and adapting to user preferences. This system is self-learning and constantly evolving. Listed on the OTCQB, Gopher Protocol is headquartered in Santa Monica, California. 

The Company is developing a real-time, heuristic based, mobile technology. When developed, the mobile technology will consist of a smart microchip, mobile application software and supporting software, which run on a server. The system envisages the creation of a global network.

Gopher Protocol’s belief is that this will be the first system developed utilizing a human, heuristic based analysis engine. The core of this system will be its advanced microchip, which will be able to undergo installation in any mobile device worldwide. Gopher Protocol expects that this will result in an internal, private network between all mobile devices using the device through providing mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional mobile features.

The Company’s licensed technology, the Guardian Patch, could potentially save a person’s life. The new mobile tracking technology will track and protect anything one cares about, with or without GPS (Global Positioning System). The Guardian Patch is an inventive location technology. It is a stick-on tracking device. It protects and tracks everything from a phone to a loved-one or a pet. The Guardian Patch device was conceived as an offshoot of Gopher Protocol’s microchip technology called GopherInsight™.

Gopher Protocol is developing, under exclusive license, mobile, intelligent technology, which connects mobile devices via its private, secured communication protocol. This is to provide advanced features. The Guardian Patch is based on this technology. Each Guardian Patch device is connected to all others through its private, secured protocol. The device is attached onto objects, mobile or static. Upon being attached, it starts its operation as a tracking device.

The Company released a new version of Epsilon (version 2.1.) on June 15, 2017. The creation of Epsilon was to implement improvements in the semiconductor development and design industry, allowing semiconductor manufacturers to accelerate the development process of chips, and provide for the optimization of chip design so that it uses less power.

Recently, Gopher Protocol started research and development (R&D) to modify its existing product offerings of mobile tracking to include a drone tracking security feature. This new feature includes an innovative enhancement, which will enable trigger drone operation through "obeying" a remote order undergoing transmission using the GopherInsight™ radio technology from any remote location.

When this phase of development is complete, the system (hardware & software) will deploy a drone response to a potential crime scene. It may provide law enforcement with real-time video of the scene. The Company bought the domain dronerespond.com and will present its development on this domain. Moreover, Gopher Protocol is preparing to launch Orb Tracker this summer as its initial advanced tracking server designed to provide hardware and software support to Internet of Things (IoT) products.

Gopher Protocol, Inc. (GOPH), closed Wednesday's trading session at $0.49, even for the day, on 207,739 volume with 107 trades. The average volume for the last 3 months is 600,145 and the stock's 52-week low/high is $0.289/$4.85.

chart

The QualityStocks Company Corner

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) was featured today in a report by NetworkNewsWire covering many of the reasons that the company is “One to Watch.”

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.4338, off by 3.49%, on 19,507 volume with 18 trades. The average volume for the last 3 months is 15,583 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Uptick Newswire Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The Company's President and CEO, Mr. Richard T. Schumacher, joined Stock Day host Mr. Everett Jolly to discuss the Company's progress in developing its unique and proprietary Ultra Shear Technology (UST) platform, and the use of this platform to process Hemp CBD Oil into a water-soluble ''nanoemulsion''.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.81, up 1.06%, on 12,947 volume with 34 trades. The average volume for the last 3 months is 14,273 and the stock's 52-week low/high is $1.52/$4.94.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings (CSE: TCAN) (FSE: TH8), an emerging cannabis branding, transportation and distribution company, recently acquired Goodfellas Group LLC, a full-service advertising and marketing agency that specializes in the cannabis and hemp industries. To view the full article, visit: http://nnw.fm/Bd1KB.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $2.81, up 0.72%, on 58,540 volume with 45 trades. The stock's 52-week low/high is $0.769/$2.90.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), an innovator in automotive vision, announced today that its wholly owned subsidiary, Eye-Net Mobile Ltd., successfully completed a controlled trial of its Eye-Net™ accident prevention solution in collaboration with the municipality of Netanya. Eye-Net™ is a cellular-based vehicle-to-everything (V2X) accident prevention solution designed to provide pre-collision alerts in real time to pedestrians and vehicles by using smartphones and relying on existing cellular networks.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $1.9323, up 6.17%, on 4,704 volume with 23 trades. The average volume for the last 3 months is 37,463 and the stock's 52-week low/high is $1.47/$4.45.

Recent News

chart

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt Corporation (OTCQB: PCRCF) (CSE: BOLT) just announced assay results from its ongoing 2019 drilling campaign at the Cyclops, Nickel/Cobalt Project in Indonesia. VALE S.A. (NYSE: VALE) has also invested heavily in Indonesian nickel production.

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed the day's trading session at $0.1562, up 12.30%, on 58,493 volume with 18 trades. The average volume for the last 3 months is 24,078 and the stock's 52-week low/high is $0.0701/$0.587.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions (OTCQB: SGSI), a leading telecommunications engineering and infrastructure services provider, recently reduced its debt and strengthened its balance sheet. To view the full article, visit: http://nnw.fm/0GsHf.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.13, up 10.64%, on 30,024 volume with 5 trades. The average volume for the last 3 months is 52,943 and the stock's 52-week low/high is $0.071/$2.59.

Recent News

chart

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

Global Payout Inc. (OTC: GOHE) would like to take an opportunity to update its valued shareholders and other interested parties on the status of the Company’s Form 10 filing. As has been previously announced, the Company has been in engaged in a full two-year audit of its financials in preparation for the filing of its Form 10 and its submission to the Securities and Exchange Commission for review.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed the day's trading session at $0.0061, up 14.77%, on 9,484,212 volume with 153 trades. The average volume for the last 3 months is 7,276,752 and the stock's 52-week low/high is $0.0041/$0.0315.

Recent News

chart

Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands, Inc. (OTCPK: ZNGY), the nation's leading next-generation utility, announced today the launch of its newly revamped website: What is Zenergy Dot Com (www.whatiszenergy.com). The new website will offer detailed information for all services, ongoing video footage from the management team and means for future clients to contact Zenergy to learn more about the Zero Cost Program™. 

Zenergy Brands, Inc. (ZNGY) is a leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. The company’s vision is to converge smart controls (building automation) with energy conservation and retail energy to deliver comprehensive smart-energy service to customers. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions, and improve their bottom line.

The company’s cutting-edge Zero Cost Program™ reduces utility consumption by 20 to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to commercial, industrial, and municipal end-use customers. This financing mechanism allows customers to reduce water, natural gas, and electricity consumption by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program enriches businesses by immediately reducing energy consumption using smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management, and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) permits Zenergy to retain a portion of these utility savings in exchange for financing the upgraded, retrofit equipment, and installation costs until a specified and agreed upon repayment period with the client ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 and 45 percent of total utility costs.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production.

According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025, which is where Zenergy will focus its efforts in 2019 and beyond. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0002, up 100.00%, on 62,844,472 volume with 27 trades. The average volume for the last 3 months is 130,539,701 and the stock's 52-week low/high is $0.000009/$0.013.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Companies Exploring Solar Energy, Establishing Foothold in Hot Industry," featuring SinglePoint Inc. (OTCQB: SING). To hear the NetworkNewsAudio version, visit: http://nnw.fm/P4d7A. To read the full editorial, visit: http://nnw.fm/RbZC4.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.019, even for the day, on 2,261,834 volume with 108 trades. The average volume for the last 3 months is 6,254,712 and the stock's 52-week low/high is $0.0106/$0.0709.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, announced the planned launch of coffee infused with CBD. YGYI had been working on a CBD coffee with the launch of its HempFX™ line of full-spectrum CBD products with ambition of being able to provide specific dosing via a K-Cup or single-serve delivery system. 

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.29, off by 5.41%, on 200,843 volume with 946 trades. The average volume for the last 3 months is 209,620 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSXV: FLWR) (OTC: FLWPF) (“Flowr” or the “Company”), a Canadian licensed producer of premium cannabis products, today announced the promotion of Jason Broome to the role of Chief Research and Innovation Officer (CRIO).  Mr. Broome previously served as Senior Vice President of Operations.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $5.49, off by 0.54%, on 150,105 volume with 297 trades. The average volume for the last 3 months is 127,270 and the stock's 52-week low/high is $2.74/$8.00.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Precision Extraction Corporation (DBA Precision Extraction Solutions, "Precision" or "the Company"), a market leader in cannabis and hemp extraction technology, is pleased to announce it has received a significant capital investment from Rivers Innovations Inc. ("Rivers Innovations"), a private U.S. focused growth capital and strategic support platform founded and advised by the seed investment and strategic advisory group behind Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF).

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.57, off by 3.79%, on 932,320 volume with 1,484 trades. The average volume for the last 3 months is 592,811 and the stock's 52-week low/high is $2.40/$11.82.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a publication from Financialnewsmedia.com, examining how anyone who has been trying to keep abreast of where the cannabis markets are and where they may be going, revenue-wise, will have undoubtedly come across revenue projections in the headlines of almost every article. There is a reason for that. In fact, its because it seems that most, if not all projections, foreshadow all the ones that have come before.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.31, off by 0.60%, on 2,007,206 volume with 2,509 trades. The average volume for the last 3 months is 1,121,571 and the stock's 52-week low/high is $1.606/$7.89.

Recent News

chart

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) a royalty company for the U.S. licensed medical cannabis industry announces that it has received US$3.9 million as partial repayment of an outstanding secured loan from Cultivation Technologies Inc. (“CTI”). These funds were generated from the sale of CTI’s Coachella property as initially announced on October 9, 2018.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.1343, off by 1.97%, on 141,838 volume with 51 trades. The average volume for the last 3 months is 42,217 and the stock's 52-week low/high is $0.0577/$0.626.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.